Skip to content

Clinical trials

Phase 3 Hypersensitivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 3 Country / region: United States Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20072
20084
20091
20103
20112
20121
20133
20151
20161
20174
20185
20201
20212
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Withdrawn2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aimmune Therapeutics, Inc.4
AstraZeneca4
Ellodi Pharmaceuticals, LP3
Allergy Therapeutics2
Bayer2
Celgene2
Colgate Palmolive2
DBV Technologies2
Greer Laboratories2
Pearl Network2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity40
Hypersensitivity, Immediate9
Immune System Diseases8
Rhinitis, Allergic7
Rhinitis, Allergic, Seasonal7
Gastroenteritis6
Peanut Hypersensitivity6
Eosinophilia5
Eosinophilic Esophagitis5
Esophageal Diseases5

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.